A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients.

Singh, D; Magnussen, H; Kirsten, A; Mindt, S; Caracta, C; Seoane, B; Jarreta, D; Garcia Gil, E

Singh, D; Magnussen, H; Kirsten, A; Mindt, S; Caracta, C; Seoane, B; Jarreta, D; Garcia Gil, E.

Affiliation

Singh D; University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester, Langley Building, Southmoor Road, Manchester M23 9QZ, UK. dsingh@meu.org.uk

Pulm Pharmacol Ther ; 25(3): 248-53, 2012 Jun.

Article in En | MEDLINE | ID: mdl-22497752

Subject(s)

Bronchodilator Agents/therapeutic use; Ethanolamines/therapeutic use; Pulmonary Disease, Chronic Obstructive/drug therapy; Tropanes/therapeutic use; Administration, Inhalation; Aged; Area Under Curve; Bronchodilator Agents/administration & dosage; Bronchodilator Agents/adverse effects; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Ethanolamines/administration & dosage; Ethanolamines/adverse effects; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive/physiopathology; Treatment Outcome; Tropanes/administration & dosage; Tropanes/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tropanes / Bronchodilator Agents / Pulmonary Disease, Chronic Obstructive / Ethanolamines Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Pulm Pharmacol Ther Journal subject: FARMACOLOGIA Year: 2012 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google